EFC (I)
|
EFC (I) Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 16.87 | 14.27 | 11.65 | 6.35 | 0.18 |
| CEPS(Rs) | 25.46 | 23.78 | 13.74 | 5.53 | 0.02 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 58.80 | 57.44 | 85.74 | 103.05 | 23.55 |
| Tax Rate(%) | 24.04 | 29.56 | 21.82 | 46.27 | 34.03 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 45.17 | 49.89 | 43.53 | 53.69 | - |
| EBIT Margin(%) | 35.22 | 37.39 | 27.72 | 21.08 | - |
| Pre Tax Margin(%) | 29.80 | 30.43 | 19.30 | 6.96 | - |
| PAT Margin (%) | 22.64 | 21.44 | 15.09 | 3.74 | - |
| Cash Profit Margin (%) | 34.23 | 36.61 | 33.12 | 37.17 | - |
| Performance Ratios | |||||
| ROA(%) | 10.74 | 10.52 | 8.71 | 1.62 | 0.76 |
| ROE(%) | 34.03 | 28.19 | 25.47 | 10.73 | 0.76 |
| ROCE(%) | 37.93 | 36.31 | 34.56 | 32.82 | 1.17 |
| Asset Turnover(x) | 0.47 | 0.49 | 0.58 | 0.43 | - |
| Sales/Fixed Asset(x) | 1.04 | 0.97 | 0.96 | 0.25 | - |
| Working Capital/Sales(x) | 10.54 | 4.41 | 1.40 | -9.60 | - |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.96 | 1.04 | 1.04 | 4.05 | - |
| Receivable days | 60.38 | 61.86 | 60.42 | 51.57 | - |
| Inventory Days | 7.06 | 10.50 | 30.62 | - | - |
| Payable days | 1,237.61 | 1,358.67 | 206.58 | - | - |
| Valuation Parameters | |||||
| PER(x) | 10.40 | 17.08 | 14.18 | 14.87 | - |
| PCE(x) | 6.89 | 10.25 | 11.83 | 16.82 | - |
| Price/Book(x) | 3.03 | 4.31 | 3.85 | 9.17 | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.57 | 3.89 | 3.75 | 6.79 | - |
| EV/Core EBITDA(x) | 5.49 | 7.40 | 8.20 | 12.45 | 2.45 |
| EV/EBIT(x) | 7.30 | 10.41 | 13.54 | 32.20 | 2.45 |
| EV/CE(x) | 2.39 | 3.15 | 2.90 | 5.35 | 0.03 |
| M Cap / Sales | 2.36 | 3.75 | 3.92 | 6.25 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 57.85 | 56.57 | 306.40 | - | - |
| Core EBITDA Growth(%) | 40.62 | 79.87 | 241.15 | - | - |
| EBIT Growth(%) | 48.71 | 111.13 | 434.47 | - | - |
| PAT Growth(%) | 66.69 | 122.38 | 1,538.94 | - | - |
| EPS Growth(%) | 18.16 | 22.55 | 83.31 | 3,428.32 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.38 | 0.40 | 0.27 | 0.83 | - |
| Current Ratio(x) | 1.16 | 1.46 | 2.90 | 0.90 | 134.71 |
| Quick Ratio(x) | 1.10 | 1.45 | 2.67 | 0.90 | 134.71 |
| Interest Cover(x) | 6.50 | 5.37 | 3.29 | 1.49 | 192.00 |
| Total Debt/Mcap(x) | 0.13 | 0.09 | 0.07 | 0.09 | - |
Compare Financial Ratios of peers of EFC (I)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EFC (I) | ₹2,677.0 Cr | 1.6% | -9.1% | -41.9% | Stock Analytics | |
| PRIME FOCUS | ₹24,823.4 Cr | -7.5% | 5.4% | 77.7% | Stock Analytics | |
| SAGILITY | ₹21,019.2 Cr | -1.6% | 4.3% | -1.1% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,355.6 Cr | 3% | -6.4% | -42% | Stock Analytics | |
| INDEGENE | ₹14,300.2 Cr | -0.7% | 5.3% | 2.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,045.2 Cr | -1.8% | -5.5% | -12.2% | Stock Analytics | |
EFC (I) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EFC (I) | 1.6% |
-9.1% |
-41.9% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses
